These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35628845)

  • 1. Physical Activity, Positive and Negative Symptoms of Psychosis, and General Psychopathology among People with Psychotic Disorders: A Meta-Analysis.
    Swora E; Boberska M; Kulis E; Knoll N; Keller J; Luszczynska A
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2018; 18(5):1-141. PubMed ID: 30443277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between vitamin D and symptom domains in psychotic disorders: A systematic review.
    Tsiglopoulos J; Pearson N; Mifsud N; Allott K; O'Donoghue B
    Schizophr Res; 2021 Nov; 237():79-92. PubMed ID: 34509104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH).
    Stubbs B; Vancampfort D; Hallgren M; Firth J; Veronese N; Solmi M; Brand S; Cordes J; Malchow B; Gerber M; Schmitt A; Correll CU; De Hert M; Gaughran F; Schneider F; Kinnafick F; Falkai P; Möller HJ; Kahl KG
    Eur Psychiatry; 2018 Oct; 54():124-144. PubMed ID: 30257806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysis.
    Beck K; Hindley G; Borgan F; Ginestet C; McCutcheon R; Brugger S; Driesen N; Ranganathan M; D'Souza DC; Taylor M; Krystal JH; Howes OD
    JAMA Netw Open; 2020 May; 3(5):e204693. PubMed ID: 32437573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.
    Yung AR; Phillips LJ; Yuen HP; McGorry PD
    Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive biases are associated with clinical and functional variables in psychosis: A comparison across schizophrenia, early psychosis and healthy individuals.
    Ahuir M; Crosas JM; Estrada F; Zabala W; Pérez-Muñoz S; González-Fernández A; Tost M; Aguayo R; Montalvo I; Miñano MJ; Gago E; Pàmias M; Monreal JA; Palao D; Labad J
    Rev Psiquiatr Salud Ment (Engl Ed); 2021; 14(1):4-15. PubMed ID: 32950409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical Activity Levels and Psychosis: A Mediation Analysis of Factors Influencing Physical Activity Target Achievement Among 204 186 People Across 46 Low- and Middle-Income Countries.
    Stubbs B; Koyanagi A; Schuch F; Firth J; Rosenbaum S; Gaughran F; Mugisha J; Vancampfort D
    Schizophr Bull; 2017 May; 43(3):536-545. PubMed ID: 27562855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the experience of initiating community-based group physical activity by people with serious mental illness: A systematic review using a meta-ethnographic approach.
    Quirk H; Hock E; Harrop D; Crank H; Peckham E; Traviss-Turner G; Machaczek K; Stubbs B; Horspool M; Weich S; Copeland R
    Eur Psychiatry; 2020 Oct; 63(1):e95. PubMed ID: 33087211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysis.
    Jeppesen R; Christensen RHB; Pedersen EMJ; Nordentoft M; Hjorthøj C; Köhler-Forsberg O; Benros ME
    Brain Behav Immun; 2020 Nov; 90():364-380. PubMed ID: 32890697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptance- and mindfulness-based interventions for persons with psychosis: A systematic review and meta-analysis.
    Jansen JE; Gleeson J; Bendall S; Rice S; Alvarez-Jimenez M
    Schizophr Res; 2020 Jan; 215():25-37. PubMed ID: 31780349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for a systematic review and meta-analysis of cognitive-behavioural therapy for social anxiety disorder in psychosis.
    Michail M; Birchwood M; Tait L
    Syst Rev; 2014 Jun; 3():62. PubMed ID: 24920188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.
    Berger M; Nelson B; Markulev C; Yuen HP; Schäfer MR; Mossaheb N; Schlögelhofer M; Smesny S; Hickie IB; Berger GE; Chen EYH; de Haan L; Nieman DH; Nordentoft M; Riecher-Rössler A; Verma S; Mitchell TW; Meyer BJ; Thompson A; Yung AR; McGorry PD; Amminger GP
    Front Psychiatry; 2019; 10():393. PubMed ID: 31244693
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the psychosis continuum: differential impact of genetic and nongenetic risk factors and comorbid psychopathology across the entire spectrum of psychosis.
    Binbay T; Drukker M; Elbi H; Tanık FA; Özkınay F; Onay H; Zağlı N; van Os J; Alptekin K
    Schizophr Bull; 2012 Sep; 38(5):992-1002. PubMed ID: 21525167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression.
    Stubbs B; Firth J; Berry A; Schuch FB; Rosenbaum S; Gaughran F; Veronesse N; Williams J; Craig T; Yung AR; Vancampfort D
    Schizophr Res; 2016 Oct; 176(2-3):431-440. PubMed ID: 27261419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.
    Abdin E; Chong SA; Vaingankar JA; Peh CX; Poon LY; Rao S; Verma S; Subramaniam M
    PLoS One; 2017; 12(11):e0187141. PubMed ID: 29095875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early intervention for psychosis.
    Marshall M; Rathbone J
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.